申请人:Dininno Frank
公开号:US20100279983A1
公开(公告)日:2010-11-04
This invention provides novel β-lactamase inhibitors of the aryl- and heteroarylsulfonamidomethylphosphonate monoester class having nitrogen-based cations or quarternary ammonium groups. The compounds inhibit three classes of β-lactamases and synergize the antibacterial effects of β-lactam antibiotics (e.g., imipenem and ceftazidime) against those micro-organisms normally resistant to the β-lactam antibiotics as a result of the presence of the β-lactamases. Formula (I) or pharmaceutically acceptable salt thereof.
这项发明提供了一种新型的β-内酰胺酶抑制剂,属于芳基和杂芳基磺酰胺基甲基膦酸单酯类,具有基于氮的阳离子或季铵基团。这些化合物抑制三类β-内酰胺酶,并增强β-内酰胺类抗生素(如亚胺培南和头孢他啶)对那些通常对β-内酰胺类抗生素具有抗药性的微生物的抗菌效果,这是由于β-内酰胺酶的存在。公式(I)或其药学上可接受的盐。